Company Filing History:
Years Active: 2018-2021
Title: Doo Hwan Jung: Innovator in Self-Immolative Linkers
Introduction
Doo Hwan Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of innovative compounds that utilize self-immolative linkers. With a total of 5 patents to his name, Jung's work is paving the way for advancements in targeted drug delivery systems.
Latest Patents
One of his latest patents is titled "Compound bearing beta-galactoside-introduced self-immolative linker." This invention relates to a compound that features a self-immolative linker with a β-galactoside component. The self-immolative linker can form a glycosidic bond with proteins or ligands that have a specific affinity for desired targets. This allows for the selective release of active agents within target cells, enhancing the efficacy of therapeutic applications. Another notable patent is "Compounds comprising self-immolative group," which includes compounds that consist of a self-immolative group, potentially involving proteins and active agents with specific functions.
Career Highlights
Doo Hwan Jung has worked with notable companies in the biotechnology sector, including Legochem Biosciences, Inc. and Intocell, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of biochemistry.
Collaborations
Throughout his career, Jung has collaborated with talented individuals such as Tae Kyo Park and Sung Ho Woo. These collaborations have likely enriched his research and development efforts, leading to groundbreaking inventions.
Conclusion
Doo Hwan Jung is a distinguished inventor whose work in self-immolative linkers is making a significant impact in the field of targeted drug delivery. His innovative patents and collaborations highlight his commitment to advancing biochemistry and improving therapeutic outcomes.